Kindred Biosciences (KIN) Tops Q3 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Kindred Biosciences (KIN) Tops Q3 EPS by 8c

Kindred Biosciences Announces Third Quarter 2015 Financial Results

November 9, 2015 8:30 AM EST

SAN FRANCISCO, Nov. 9, 2015 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the third quarter ended September 30, 2015 and provided updates on its programs.  

Development and Corporate Updates

KindredBio continues to advance a diversified portfolio of molecules in a capital efficient manner. Some of the recent highlights include:

SentiKind, or KIND-090, pivotal study. The pivotal field study of SentiKind, a KCNQ potassium channel agonist for post-operative pain in dogs, completed enrollment and the Company plans to report topline results in the coming weeks. The... More